Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205]
- Status
- TERMINATED
- Phase
- PHASE2
Resection Observatory
- Status
- COMPLETED
- Phase
- N/A
BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of FIRTECH in Patients With Mild to Moderate Acute Low Back Pain
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis
- Status
- TERMINATED
- Phase
- PHASE3
Sutimlimab (BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Completed Phase 3 Studies (CARDINAL or CADENZA) in Japan
- Status
- COMPLETED
- Phase
- PHASE3
Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study
- Status
- COMPLETED
- Phase
- PHASE2
Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE4
Non-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 ml SYDNEY Auto-injector
- Status
- COMPLETED
- Phase
- N/A
Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity
- Status
- TERMINATED
- Phase
- PHASE3
Pharmacokinetics of Amcenestrant in Female Hepatic Impaired Participants as Compared to Participants With Normal Hepatic Function
- Status
- TERMINATED
- Phase
- PHASE1
Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE4
Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine
- Status
- COMPLETED
- Phase
- PHASE2
Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)
- Status
- COMPLETED
- Phase
- PHASE2
Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation
- Status
- RECRUITING
- Phase
- N/A